SCYNEXIS (SCYX)
(Delayed Data from NSDQ)
$2.43 USD
+0.05 (2.10%)
Updated Jun 4, 2024 04:00 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Brokerage Reports
0 items in cart
SCYNEXIS, Inc. [SCYX]
Reports for Purchase
Showing records 61 - 66 ( 66 total )
Company: SCYNEXIS, Inc.
Industry: Medical - Drugs
SCY-078 ECCMID Abstracts Indicate Micafungin Won''t Go Down Easily
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAVIS C
Company: SCYNEXIS, Inc.
Industry: Medical - Drugs
All Eyes on Q2 FDA Meeting While Oral ''078 Program Progresses as Promised
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAVIS C
Company: SCYNEXIS, Inc.
Industry: Medical - Drugs
IV ''078 Clinical Hold Will Cause Delay But Shouldn''t Affect Outcome
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAVIS C
Company: SCYNEXIS, Inc.
Industry: Medical - Drugs
Company: SCYNEXIS, Inc.
Industry: Medical - Drugs
Uneventful Q3 Release as We Look to Results of IV ''078 Trial This Month
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAVIS C